Daiwa Securities Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
258
| – | – | ﹤0.01% | 1178 |
|
|
2025
Q1 | $5K | Hold |
258
| – | – | ﹤0.01% | 1136 |
|
|
2024
Q4 | $4K | Hold |
258
| – | – | ﹤0.01% | 1180 |
|
|
2024
Q3 | $4K | Hold |
258
| – | – | ﹤0.01% | 1189 |
|
|
2024
Q2 | $2K | Hold |
258
| – | – | ﹤0.01% | 1260 |
|
|
2024
Q1 | $2K | Hold |
258
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q4 | $2K | Hold |
258
| – | – | ﹤0.01% | 1274 |
|
|
2023
Q3 | $2K | Hold |
258
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q2 | $4K | Hold |
258
| – | – | ﹤0.01% | 1196 |
|
|
2023
Q1 | $6K | Hold |
258
| – | – | ﹤0.01% | 1132 |
|
|
2022
Q4 | $5K | Buy |
258
+50
| +24% | +$969 | ﹤0.01% | 1152 |
|
|
2022
Q3 | $5K | Hold |
208
| – | – | ﹤0.01% | 1158 |
|
|
2022
Q2 | $5K | Hold |
208
| – | – | ﹤0.01% | 1167 |
|
|
2022
Q1 | $5K | Hold |
208
| – | – | ﹤0.01% | 1173 |
|
|
2021
Q4 | $6K | Hold |
208
| – | – | ﹤0.01% | 1178 |
|
|
2021
Q3 | $5K | Buy |
208
+94
| +82% | +$2.26K | ﹤0.01% | 1178 |
|
|
2021
Q2 | $2K | Hold |
114
| – | – | ﹤0.01% | 1156 |
|
|
2021
Q1 | $3K | Buy |
114
+18
| +19% | +$474 | ﹤0.01% | 1121 |
|
|
2020
Q4 | $3K | Sell |
96
-167
| -63% | -$5.22K | ﹤0.01% | 1097 |
|
|
2020
Q3 | $5K | Hold |
263
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q2 | $4K | Hold |
263
| – | – | ﹤0.01% | 1112 |
|
|
2020
Q1 | $4K | Hold |
263
| – | – | ﹤0.01% | 1113 |
|
|
2019
Q4 | $4K | Hold |
263
| – | – | ﹤0.01% | 1119 |
|
|
2019
Q3 | $3K | Hold |
263
| – | – | ﹤0.01% | 1095 |
|
|
2019
Q2 | $5K | Hold |
263
| – | – | ﹤0.01% | 1086 |
|
|
2019
Q1 | $6K | Buy |
263
+46
| +21% | +$1.05K | ﹤0.01% | 1058 |
|
|
2018
Q4 | $5K | Hold |
217
| – | – | ﹤0.01% | 1048 |
|
|
2018
Q3 | $6K | Hold |
217
| – | – | ﹤0.01% | 1060 |
|
|
2018
Q2 | $6K | Hold |
217
| – | – | ﹤0.01% | 1075 |
|
|
2018
Q1 | $5K | Buy |
+217
| New | +$5K | ﹤0.01% | 1068 |
|